Alzheimer's disease is a progressive brain disorder that leads to memory loss, cognitive decline, and the inability to carry out daily activities.
The National Institutes of Health (NIH) has released a comprehensive progress report on dementia research, highlighting advancements in Alzheimer's disease and related dementias.
A large-scale study funded by the NIA has revealed new insights into the role of brain proteins in Alzheimer's disease.
Changes in brain proteins play a significant role in the progression of Alzheimer's disease, and understanding these changes may help identify potential therapeutic targets and biomarkers.
Researchers have discovered protein networks associated with Alzheimer's that can provide valuable clues about the disease and its stages.
Directly analyzing proteins, in addition to RNA, can offer a more comprehensive understanding of how Alzheimer's affects the brain.
The NIH progress report highlights several notable advancements, including an anti-beta-amyloid vaccine, gene therapy trials, and the development of a blood test for Alzheimer's biomarkers.
Sex differences in Alzheimer's have been linked to a specific hormone, and speed of processing training may help delay cognitive impairment.
Research has also explored the connection between dementia and infectious diseases like COVID-19.
Collaboration among researchers, clinicians, individuals living with dementia, and their families is crucial for advancing Alzheimer's and related dementia research.